Trial NCT01904253

View at ClinicalTrials.gov 
Org. Study IDs: TPU-TAS-102-201
Secondary IDs: 2012-004793-26

Last trial update was posted on 2014-07-14

MeSH Interventions

Amrubicin Topotecan

MeSH Conditions

Lung Neoplasms Small Cell Lung Carcinoma

Other Conditions

Small Cell Lung Cancer (SCLC)

Stopping Reasons

The preliminary data does not suggest any safety signal, but an ad hoc interim analysis showed an imbalance of PFS between the two arms

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID